Ipca Laboratories
IPCALABNSE

Ipca Laboratories

₹1,509.10-25.90 (1.69%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
1,499.00
Today’s high
1,544.80
52 week low
1,251.60
52 week high
1,624.00
Open price
1,535.00
Previous close
1,535.00
Live volume
5,07,486
Lower circuit
1,228.00
Upper circuit
1,842.00

Fundamentals

Market Cap
₹38,900Cr
ROE
13.33%
P/E Ratio(TTM)
41.34
EPS(TTM)
37.09
P/B Ratio
5.24
Dividend Yield
0.26%
Industry P/E
34.27
Book Value
292.74
Debt to Equity
0.17
Face Value
1

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹2,413
-6.64%
Profit (Cr)
₹364
+28.41%
07001.4k2.1k2.8k
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Revenue growthValue
1Y (TTM)+6%
3Y CAGR+15%
Profit growthValue
1Y (TTM)+31%
3Y CAGR-5%

About

Ipca Laboratories Limited, established in 1949, is a fully integrated Indian pharmaceutical company that develops, manufactures, and markets a wide range of medicines. The company's primary business is the manufacturing and marketing of pharmaceuticals, producing both active ingredients (APIs) and over 350 ready-to-use formulations. In the Indian market, the company operates through 22 marketing divisions and is ranked as the 16th largest in the domestic formulations business. It has a vast global presence, with its products being exported to more than 100 countries across the world. Ipca drives innovation through its R&D centers, focusing on new processes for APIs and developing modern drug delivery systems. As part of its sustainability initiatives, the company has been investing in renewable energy projects such as wind and solar power generation for its own use.;
CEO/MD
Pranay Godha
Founded in
1949
NSE symbol
IPCALAB

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
44.72%
Mutual Funds
31.24%
Foreign Institutions
10.63%
Retail And Others
7.20%
Other Domestic Institutions
6.21%

Mutual Funds Invested (4)

Livesquawk
IPCA Labs saw an NSE block trade worth Rs. 16.05 crore for 103,156 shares. The trade was executed at Rs. 1,555.70 per share.
Livesquawk
IPCA Labs saw an NSE block trade of Rs. 60.65 cr for 381,656 shares at Rs. 1,589 each.
Livesquawk
IPCA Labs forecasts 10-11% overall growth, with branded, generic, and domestic segments rising 10-12%. EBITDA margin may improve by 1.5% annually, indicating a 300 bps increase over two years.
Livesquawk
IPCA Labs posts Q3 consolidated net profit of 3.3B INR, up from 2.5B YoY. The performance reflects strong growth trajectory for IPCA Laboratories.
2026
29
May
Annual Result
Upcoming
Release date
13
Feb
Quarterly Result
Release date
2025
13
Nov
Quarterly Result
Release date
11
Aug
Quarterly Result
Release date

5
Aug
Dividend
Ex date
₹2.00
per share

For each share you hold, you will receive ₹2.00
Dividend amount₹2.00 per share
Dividend TypeFinal
Ex Date5 Aug ‘25
Record Date5 Aug ‘25
Announcement date29 May ‘25

29
May
Dividend
Announced
₹2.00
per share

For each share you hold, you will receive ₹2.00
Dividend amount₹2.00 per share
Dividend TypeFinal
Ex Date5 Aug ‘25
Record Date5 Aug ‘25
Announcement date29 May ‘25
2024

27
Nov
Dividend
Ex date
₹2.00
per share

For each share you hold, you will receive ₹2.00
Dividend amount₹2.00 per share
Dividend TypeInterim
Ex Date27 Nov ‘24
Record Date27 Nov ‘24
Announcement date14 Nov ‘24

14
Nov
Dividend
Announced
₹2.00
per share

For each share you hold, you will receive ₹2.00
Dividend amount₹2.00 per share
Dividend TypeInterim
Ex Date27 Nov ‘24
Record Date27 Nov ‘24
Announcement date14 Nov ‘24

6
Aug
Dividend
Ex date
₹2.00
per share

For each share you hold, you will receive ₹2.00
Dividend amount₹2.00 per share
Dividend TypeFinal
Ex Date6 Aug ‘24
Record Date7 Aug ‘24
Announcement date29 May ‘24

29
May
Dividend
Announced
₹2.00
per share

For each share you hold, you will receive ₹2.00
Dividend amount₹2.00 per share
Dividend TypeFinal
Ex Date6 Aug ‘24
Record Date7 Aug ‘24
Announcement date29 May ‘24
Events calendar
View upcoming events in other stocks